investorscraft@gmail.com

Intrinsic ValueZhejiang Jianye Chemical Co., Ltd. (603948.SS)

Previous Close$31.31
Intrinsic Value
Upside potential
Previous Close
$31.31

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Zhejiang Jianye Chemical Co., Ltd. operates as a specialized chemical manufacturer within China's basic materials sector, producing a diversified portfolio of industrial chemicals including low carbon fatty amines, plasticizers, acetates, and liquid sulfur dioxide. The company generates revenue through both domestic sales and a global export business, serving various downstream industries that require these essential inputs. Its market position is that of a niche player focused on specific chemical intermediates, rather than a bulk commodity producer. This specialization allows it to cultivate deep customer relationships and maintain a stable, though geographically concentrated, operational footprint. The competitive landscape is defined by technical manufacturing capabilities, consistent product quality, and supply chain reliability, which are critical for industrial clients. While not a market leader in scale, the firm leverages its integrated production and technical expertise to serve targeted applications, positioning itself as a reliable supplier in its chosen chemical segments.

Revenue Profitability And Efficiency

The company reported revenue of CNY 2.39 billion with net income of CNY 209 million, translating to a net profit margin of approximately 8.7%. This indicates moderate profitability within the chemical manufacturing sector. Operating cash flow of CNY 292 million significantly exceeded capital expenditures, demonstrating solid cash generation from core operations relative to investment needs.

Earnings Power And Capital Efficiency

Diluted EPS stands at CNY 1.29, reflecting the company's earnings capacity per share. The substantial operating cash flow of CNY 292 million, which comfortably covers capital expenditures of CNY 31 million, indicates strong fundamental earnings power and efficient reinvestment of capital into the business without excessive outlays.

Balance Sheet And Financial Health

The balance sheet appears robust with cash and equivalents of CNY 1.13 billion significantly exceeding total debt of CNY 278 million. This conservative financial structure provides ample liquidity and low financial risk, with a strong capacity to withstand industry cyclicality or pursue strategic opportunities without leverage pressure.

Growth Trends And Dividend Policy

The company maintains a shareholder-friendly approach with a dividend per share of CNY 1.00, representing a substantial payout relative to its EPS. This policy indicates management's confidence in sustainable cash generation and commitment to returning capital to shareholders, while maintaining sufficient retained earnings for operational needs and potential growth initiatives.

Valuation And Market Expectations

With a market capitalization of approximately CNY 4.12 billion and a beta of 0.564, the market values the company at a moderate multiple relative to its earnings. The low beta suggests investors perceive it as less volatile than the broader market, possibly reflecting its stable chemical niche and strong balance sheet, which may provide defensive characteristics.

Strategic Advantages And Outlook

The company's strategic advantages include its specialized chemical portfolio, export capabilities, and exceptionally strong balance sheet. The outlook remains contingent on global chemical demand cycles, but its financial health provides significant resilience. Future performance will depend on maintaining technical competitiveness and efficiently deploying its substantial cash reserves.

Sources

Company Financial ReportsShanghai Stock Exchange disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount